comparemela.com

Latest Breaking News On - Paul hadden - Page 1 : comparemela.com

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.

Boston
Massachusetts
United-states
China
Beijing
Japan
Tavo-espinoza
Amgen-kyprolis
Todd-davis
Paul-hadden
Matt-hewitt
Matthew-korenberg

Jedburgh: Man who assaulted retail worker gets jail sentence

Sheriff Peter Paterson imposed a six-month jail sentence for the assault on the retail worker and another six-month for the other offences.

Jedburgh
Scottish-borders
The
United-kingdom
Hawick
Peter-paterson
Paul-hadden
Grieve-avenue

Jedburgh: Man who assaulted retail worker gets jail sentence

Sheriff Peter Paterson imposed a six-month jail sentence for the assault on the retail worker and another six-month for the other offences.

Hawick
Scottish-borders
The
United-kingdom
Jedburgh
Peter-paterson
Paul-hadden
Grieve-avenue

Ligand to Host Investor and Analyst Day on December 12, 2023 in New York City

SAN DIEGO (BUSINESS WIRE) Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host its Investor and Analyst Day on Tuesday, December 12, 2023.Members of Ligand’s senior management team will provide an update on the company’s strategy and portfolio as well as a multi-year financial outlook and a 2024 guidance p.

Ukraine
Russia
Israel
New-york
United-states
Matt-korenberg
Primrose-bio
Todd-davis
Tavo-espinoza
Paul-hadden
Amgen
Exchange-commission

Ligand to Host Investor and Analyst Day on December 12, 2023 in New York City

Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023. Members of Ligand’s senior management team will provide an update on the company’s.

New-york
United-states
Ukraine
Israel
Russia
Matt-korenberg
Primrose-bio
Todd-davis
Tavo-espinoza
Paul-hadden
Gilead-sciences
Business-development

vimarsana © 2020. All Rights Reserved.